NICE issues final guidance on the use of cetuximab for the treatment of head and neck cancer – 24 June 2009

Posted on June 25, 2009. Filed under: Oncology | Tags: , |

2009/040 NICE issues final guidance on the use of cetuximab for the treatment of head and neck cancer

Press release

Guidance

“The National Institute for Health and Clinical Excellence (NICE) has today (24 June) published guidance on cetuximab for the treatment of recurrent and/or metastatic (where the cancer has spread) squamous cell cancer of the head and neck. The guidance does not recommend cetuximab in combination with platinum- based chemotherapy as a treatment option for patients with this type of head and neck cancer.”

Advertisements

Make a Comment

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: